A mutation-based approach is currently one of the few feasible methods to explore SLCs in human tumour evolution, yet it is important to acknowledge its reductionist nature in comparison to the measurement of phenotype, i.e. SLC-generated ionic or solute fluxes. This evidence concerns the gene CCL21 and neoplasm.